Kerry Group plc KRYAY
Set alert
110.84 USD +1.12 +1.02%
As of Nov 2, 2:13 PM ET
110.62 Day range 111.14
74.48 52-week range 112.87
- YTD
- +21.67%
- 1 year
- +20.68%
- Open
- 111.14
- Prev close
- 109.72
- Mkt cap
- 17.62B
- Vol
- 281
- Avg vol
- 17.51K
- EPS
- 4.58
- P/E
- 24.20
More statistics
- Low
- 110.62
- High
- 111.14
6M chart
Events in this range
- Oct 9, 2026Dividend: 0.52668
Signals (22)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 22, 2026 | 1 week ago |
| RSI: Overbought | Oct 15, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 6, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 2, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 21, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 15, 2026 | 3 months ago |
| RSI: Overbought | Jul 2, 2026 | 4 months ago |
| RSI: Overbought | Jun 26, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 23, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 17, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 11, 2026 | 4 months ago |
| SMA: Bullish | Jun 9, 2026 | 4 months ago |
| SMA: Bearish | Jun 4, 2026 | 5 months ago |
| MACD: Sell Signal | May 28, 2026 | 5 months ago |
| SMA: Bullish | May 12, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 16, 2026 | Dec 31, 2025 | — | 2.58 | — | — |
| Aug 4, 2025 | Jun 30, 2025 | — | 2.14 | — | — |
| Feb 18, 2025 | Dec 31, 2024 | — | 2.65 | — | — |
| Jul 31, 2024 | Jun 30, 2024 | — | 1.79 | — | — |
| Feb 15, 2024 | Dec 31, 2023 | — | 2.29 | — | — |
| Jun 30, 2023 | Jun 30, 2023 | — | 2.20 | — | — |
News
- Kerry Group plc (KRYAY) Analyst/Investor Day Transcript
- Kerry Group Targets 20%-21% Margins as Biotech Fuels Taste and Nutrition Growth
- OS Therapies Appoints Kerry Clem as Chief Commercial Officer and Frank Knuettel II as Chief Financial Officer
- All You Need to Know About Kerry Group (KRYAY) Rating Upgrade to Buy
- Kerry Group plc (KRYAY) Q2 2026 Earnings Call Prepared Remarks Transcript
- Kerry Group plc (KRYAY) Q2 2026 Earnings Call Transcript
- Kerry Group plc (KRYAY) Discusses Half Year Results, Margin Expansion and 2030 Financial Targets Prepared Remarks Transcript
- HFFG vs. KRYAY: Which Stock Is the Better Value Option?
- HFFG or KRYAY: Which Is the Better Value Stock Right Now?
- HFFG vs. KRYAY: Which Stock Is the Better Value Option?
Your note
Sign in to keep a note on KRYAY — it syncs with the Stock Master app.